E-Selectin Represents Promising Direction for AML Treatment Focus
Oncology Nursing News,
Acute myeloid leukemia (AML) currently holds the lowest 5-year survival rate of all the leukemias at 29.5%, compared with 70.6…
Acute myeloid leukemia (AML) currently holds the lowest 5-year survival rate of all the leukemias at 29.5%, compared with 70.6…
In Partnership With: In acute myeloid leukemia, investigators are exploring novel agents engineered to target adhesion factors…